Business Context and Reporting Period
This Form 6-K is filed by pSivida Limited, a foreign issuer, for the month of May 2005. The report was signed on May 16, 2005, by Aaron Finlay, Chief Financial Officer and Company Secretary. The registrant's principal executive offices are located in Perth, Western Australia.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a corporate event rather than a financial statement.
Material Changes
The primary material change disclosed is a corporate governance update. Exhibit 99.1 announces that a Vice President from Roche Diagnostics has joined the board of AION, a subsidiary or related entity of the registrant.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the board appointment.
Key Facts for Investor Verification
- Verify the specific role and background of the Roche Diagnostics executive joining the AION board.
- Confirm the strategic implications of this appointment for pSivida Limited's business operations.
- Note that this filing contains no financial performance data for the period.